Zhang R - Search Results

1

Comparison of dihydropyrimidine dehydrogenase from human, rat, pig and cow liver. Biochemical and immunological properties.

Lu ZH, Zhang R, Diasio RB. Lu ZH, et al. Among authors: zhang r. Biochem Pharmacol. 1993 Sep 1;46(5):945-52. doi: 10.1016/0006-2952(93)90505-q. Biochem Pharmacol. 1993. PMID: 8373446

2

Preclinical pharmacology of novel indolecarboxamide ML-970, an investigative anticancer agent.

Rayburn E, Wang W, Li M, Zhang X, Xu H, Li H, Qin JJ, Jia L, Covey J, Lee M, Zhang R. Rayburn E, et al. Among authors: zhang r, zhang x. Cancer Chemother Pharmacol. 2012 Jun;69(6):1423-31. doi: 10.1007/s00280-012-1851-9. Epub 2012 Feb 25. Cancer Chemother Pharmacol. 2012. PMID: 22367116 Free PMC article.

3

A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors.

Saif MW, Sellers S, Li M, Wang W, Cusimano L, Wang H, Zhang R. Saif MW, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2007 Nov;60(6):871-82. doi: 10.1007/s00280-007-0434-7. Epub 2007 Mar 8. Cancer Chemother Pharmacol. 2007. PMID: 17345085 Clinical Trial.

4

Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies.

Posey JA, Wang H, Hamilton J, Delgrosso A, Zhang R, Freda T, Zamboni WC. Posey JA, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2005 Aug;56(2):182-8. doi: 10.1007/s00280-004-0925-8. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838660 Clinical Trial.

5

Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent.

Wang H, Wang Z, Wang S, Li M, Nan L, Rhie JK, Covey JM, Zhang R, Hill DL. Wang H, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2005 Sep;56(3):255-60. doi: 10.1007/s00280-004-0965-0. Epub 2005 May 3. Cancer Chemother Pharmacol. 2005. PMID: 15868148

6

Anti-Inflammatory Agents for Cancer Therapy.

Rayburn ER, Ezell SJ, Zhang R. Rayburn ER, et al. Among authors: zhang r. Mol Cell Pharmacol. 2009;1(1):29-43. doi: 10.4255/mcpharmacol.09.05. Mol Cell Pharmacol. 2009. PMID: 20333321 Free PMC article.

7

In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.

Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. Wang W, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2007 Apr;59(5):589-601. doi: 10.1007/s00280-006-0300-z. Epub 2006 Aug 22. Cancer Chemother Pharmacol. 2007. PMID: 16924497

8

Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.

Li M, Wang H, Hill DL, Stinson S, Veley K, Grossi I, Peggins J, Covey JM, Zhang R. Li M, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2006 May;57(5):607-14. doi: 10.1007/s00280-005-0094-4. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331493

9

Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents.

Wang H, Li M, Rhie JK, Hockenbery DM, Covey JM, Zhang R, Hill DL. Wang H, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2005 Sep;56(3):291-8. doi: 10.1007/s00280-004-0978-8. Epub 2005 May 10. Cancer Chemother Pharmacol. 2005. PMID: 15883820

10

Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine.

Wang H, Li M, Rinehart JJ, Zhang R. Wang H, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2004 Jun;53(6):459-67. doi: 10.1007/s00280-003-0759-9. Epub 2004 Jan 30. Cancer Chemother Pharmacol. 2004. PMID: 14752578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results